Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent Hutchison

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Analytical and Bioanalytical Chemistry|April 5, 2021
Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography-mass spectrometryCristina Sempio, Jelena Klawitter, Matthew Jackson, et al.
Annals of Internal Medicine|August 25, 2025
High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic ReviewThanitsara Rittiphairoj, Louis Leslie, Jean-Pierre Oberste, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 6, 2022
An Interpretable and Predictive Connectivity-Based Neural Signature for Chronic Cannabis UseKaustubh R Kulkarni, Matthew Schafer, Laura A Berner, et al.
Alcoholism, Clinical and Experimental Research|December 22, 2017
Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized TrialLara A Ray, ReJoyce Green, Daniel J O Roche, et al.
Substance Abuse : Research and Treatment|July 21, 2023
Maternal Childhood Maltreatment, Internal Working Models, and Perinatal Substance Use: Is There a Role for Hyperkatifeia? A Systematic ReviewAviva K Olsavsky, Isabella Chirico, Diab Ali, et al.
Journal of Neurotrauma|December 1, 2020
Use of Medical Cannabis to Treat Traumatic Brain InjuryDanielle C Hergert, Cidney Robertson-Benta, Veronik Sicard, et al.
Drug and Alcohol Dependence|June 5, 2019
Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descentAaron C Lim, Dara G Ghahremani, Erica N Grodin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?Sean P David, Raymond Niaura, George D Papandonatos, et al.
Frontiers in Neuroscience|September 6, 2016
COINSTAC: A Privacy Enabled Model and Prototype for Leveraging and Processing Decentralized Brain Imaging DataSergey M Plis, Anand D Sarwate, Dylan Wood, et al.
Current Addiction Reports|December 20, 2016
Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging FindingsTammy Chung, Antonio Noronha, Kathleen M Carroll, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Analytical and Bioanalytical Chemistry|April 5, 2021
Analysis of 14 endocannabinoids and endocannabinoid congeners in human plasma using column switching high-performance atmospheric pressure chemical ionization liquid chromatography-mass spectrometryCristina Sempio, Jelena Klawitter, Matthew Jackson, et al.
Annals of Internal Medicine|August 25, 2025
High-Concentration Delta-9-Tetrahydrocannabinol Cannabis Products and Mental Health Outcomes : A Systematic ReviewThanitsara Rittiphairoj, Louis Leslie, Jean-Pierre Oberste, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 6, 2022
An Interpretable and Predictive Connectivity-Based Neural Signature for Chronic Cannabis UseKaustubh R Kulkarni, Matthew Schafer, Laura A Berner, et al.
Alcoholism, Clinical and Experimental Research|December 22, 2017
Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized TrialLara A Ray, ReJoyce Green, Daniel J O Roche, et al.
Substance Abuse : Research and Treatment|July 21, 2023
Maternal Childhood Maltreatment, Internal Working Models, and Perinatal Substance Use: Is There a Role for Hyperkatifeia? A Systematic ReviewAviva K Olsavsky, Isabella Chirico, Diab Ali, et al.
Journal of Neurotrauma|December 1, 2020
Use of Medical Cannabis to Treat Traumatic Brain InjuryDanielle C Hergert, Cidney Robertson-Benta, Veronik Sicard, et al.
Drug and Alcohol Dependence|June 5, 2019
Neuroimaging findings from an experimental pharmacology trial of naltrexone in heavy drinkers of East Asian descentAaron C Lim, Dara G Ghahremani, Erica N Grodin, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?Sean P David, Raymond Niaura, George D Papandonatos, et al.
Frontiers in Neuroscience|September 6, 2016
COINSTAC: A Privacy Enabled Model and Prototype for Leveraging and Processing Decentralized Brain Imaging DataSergey M Plis, Anand D Sarwate, Dylan Wood, et al.
Current Addiction Reports|December 20, 2016
Brain mechanisms of Change in Addictions Treatment: Models, Methods, and Emerging FindingsTammy Chung, Antonio Noronha, Kathleen M Carroll, et al.
Pageof 5